Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Intellia Thera CS (NTLA)

Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,056,080
  • Shares Outstanding, K 96,439
  • Annual Sales, $ 36,280 K
  • Annual Income, $ -481,190 K
  • 60-Month Beta 1.77
  • Price/Sales 57.16
  • Price/Cash Flow N/A
  • Price/Book 1.86
Trade NTLA with:

Options Overview Details

View History
  • Implied Volatility 68.00% ( -2.39%)
  • Historical Volatility 44.65%
  • IV Percentile 58%
  • IV Rank 51.41%
  • IV High 89.67% on 02/16/24
  • IV Low 45.07% on 09/20/23
  • Put/Call Vol Ratio 0.41
  • Today's Volume 290
  • Volume Avg (30-Day) 980
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 32,565
  • Open Int (30-Day) 27,596

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -1.34
  • Number of Estimates 11
  • High Estimate -1.02
  • Low Estimate -1.43
  • Prior Year -1.17
  • Growth Rate Est. (year over year) -14.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.04 +0.57%
on 04/19/24
28.54 -25.86%
on 03/21/24
-6.47 (-23.42%)
since 03/19/24
3-Month
21.04 +0.57%
on 04/19/24
34.87 -39.32%
on 02/29/24
-4.39 (-17.18%)
since 01/19/24
52-Week
21.04 +0.57%
on 04/19/24
47.48 -55.43%
on 06/14/23
-16.50 (-43.81%)
since 04/19/23

Most Recent Stories

More News
2 Stocks Down 30% to Buy Right Now

These stocks have plenty of catalysts ahead.

NTLA : 21.16 (-0.75%)
MRNA : 101.19 (-0.79%)
Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week.

These two stocks could be ripe for a rebound.

TDOC : 12.99 (-1.44%)
NTLA : 21.16 (-0.75%)
Bull Market and Beyond: 3 Stocks Just Waiting to Soar

These stocks, a bargain today, are players to hold on to for the long term.

CRSP : 55.09 (-1.91%)
LLY : 730.83 (-2.03%)
PFE : 25.78 (+1.54%)
MRNA : 101.19 (-0.79%)
NTLA : 21.16 (-0.75%)
DNA : 0.8903 (-3.71%)
Better Cathie Wood Stock: Moderna vs. Intellia

Moderna and Intellia have declined in the double digits over the past year.

MRNA : 101.19 (-0.79%)
NTLA : 21.16 (-0.75%)
Is Intellia Therapeutics Stock a Buy Now?

The company's future will depend on its innovative qualities.

NTLA : 21.16 (-0.75%)
Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst

2024 could see the start of its first late-stage clinical trials.

NTLA : 21.16 (-0.75%)
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now

The futures for these two beaten-down stocks could be brighter than their recent pasts.

CRSP : 55.09 (-1.91%)
MRK : 125.56 (+0.26%)
NTLA : 21.16 (-0.75%)
MRNA : 101.19 (-0.79%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The popular money manager added to these three existing positions on Monday following disappointing financial updates earlier this month.

ROKU : 57.71 (-1.67%)
TXG : 27.99 (-3.32%)
NTLA : 21.16 (-0.75%)
Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought

These exciting players could deliver explosive growth over time.

VRTX : 395.30 (+0.46%)
ARKK : 42.38 (-1.24%)
ARKG : 23.30 (-1.06%)
CRSP : 55.09 (-1.91%)
NTLA : 21.16 (-0.75%)
Analysts Say Intellia Therapeutics Stock Could Rise 157% This Year, but Will It Happen?

Good news may be on the way, but it will be a while before it arrives.

NTLA : 21.16 (-0.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Intellia Therapeutics is a leading clinical-stage genome editing company focused on developing CRISPR/Cas9-based therapeutics. The company is pursuing two primary approaches to fully realize the transformative potential of CRISPR/Cas9 in vivo programs that use intravenously administered CRISPR as the...

See More

Key Turning Points

3rd Resistance Point 22.41
2nd Resistance Point 22.13
1st Resistance Point 21.73
Last Price 21.16
1st Support Level 21.05
2nd Support Level 20.77
3rd Support Level 20.37

See More

52-Week High 47.48
Fibonacci 61.8% 37.38
Fibonacci 50% 34.26
Fibonacci 38.2% 31.14
Last Price 21.16
52-Week Low 21.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar